Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 42.44
Day High 43.05
Open:43.03
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

FDA Grants Fast Track Designation for FARXIGA in Heart Failure
- BusinessWire - Mon Sep 16, 6:30AM CDT
BusinessWire - CMTX
Mon Sep 16, 6:30AM CDT
AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).
IMFINZI Is First Immunotherapy to Show Both Significant Survival Benefit and Improved, Durable Responses in Extensive-Stage Small Cell Lung Cancer
- BusinessWire - Mon Sep 9, 6:00AM CDT
BusinessWire - CMTX
Mon Sep 9, 6:00AM CDT
AstraZeneca today presented detailed results from the Phase III CASPIAN trial, showing IMFINZI(R) (durvalumab) significantly improved overall survival (OS) in patients with previously-untreated extensive-stage small cell lung cancer (SCLC).
Drug Delivery Systems Market to hit US$ 900 billion by 2025 - TMR
- GlobeNewswire - Thu Sep 5, 4:47AM CDT
GlobeNewswire - CMTX
Thu Sep 5, 4:47AM CDT
The global Drug Delivery Systems Market is likely to witness substantial expansion owing to growth in biologic products, and advancements in the medical industry. Drug deliveries systems mainly comprise technologies, formulations, and methods to transport active pharmaceutical ingredients into body for therapeutic effect.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 42.19 +0.72% increase
on 09/10/19
Period Open:44.34
Price movement based on the high, low and last over the given period.
45.69 -6.99% decrease
on 08/21/19
-1.85 (-4.16%) decrease
since 08/16/19
3-Month 39.55 +7.45% increase
on 06/17/19
Period Open:39.67
Price movement based on the high, low and last over the given period.
45.69 -6.99% decrease
on 08/21/19
+2.83 (+7.12%) increase
since 06/14/19
52-Week 35.30 +20.38% increase
on 01/28/19
Period Open:37.45
Price movement based on the high, low and last over the given period.
45.69 -6.99% decrease
on 08/21/19
+5.04 (+13.47%) increase
since 09/14/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).